Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
Status:
Recruiting
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
This is an open-label, single institution study evaluating the efficacy of intravenous iron
sucrose monotherapy in patients with thoracic, breast, GU and GI malignancies undergoing
neoadjuvant chemotherapy with the goal of undergoing surgical resection.